Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Grant or award Global Head of R&D acquired 168,935 shares (grant or award)
  2. 4 Grant or award SVP, General Counsel acquired 98,085 shares (grant or award)
  3. 4 Grant or award Director acquired 16,341 shares (grant or award)
  4. 4 Grant or award Director acquired 16,341 shares (grant or award)
  5. 4 Grant or award Director acquired 16,341 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 490,464 shares (grant or award)
  7. 4 Grant or award Director acquired 16,341 shares (grant or award)
  8. 4 Grant or award Director acquired 16,341 shares (grant or award)
  9. 4 Grant or award Director acquired 108,992 shares (grant or award)
  10. 4 Grant or award Director acquired 16,341 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 136,240 shares (grant or award)
  12. 4 Grant or award Director acquired 16,341 shares (grant or award)
  13. 4 Grant or award Director acquired 65,364 shares (grant or award)
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 8-K Event Executive or director change · Shareholder vote results
  16. 144 Insider Sale of Securities
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Other events
  19. ARS Other Annual Report to Security Holders
  20. DEF 14A Proxy Proxy Statement

Page 21 of 64 · 1,278 filings